All lobbying clients

BCBSM Inc.

BCBSM Inc. has lobbied on its own behalf in 7 filings since 2025, with $206,000 in reported spending; the newest was posted October 21, 2026.

As filed: BCBSM INC. Client based in Minnesota.

$206,000 Reported spend

7 Filings counted

0 Outside firms hired

82 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (107398), filed by the registrant listed below.

Who filed for this client 1

BCBSM, Inc. $206,000 In-house, the client's own filings · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings top 30 of 82

H.R. 10545
American Relief Act, 2025

7 filings
H.R. 1909
Preventing Maternal Deaths Reauthorization Act of 2025

7 filings
S. 1040
Drug Competition Enhancement Act

7 filings
S. 1041
Affordable Prescriptions for Patients Act

7 filings
S. 1095
Stop STALLING Act

7 filings
S. 1096
Preserve Access to Affordable Generics and Biosimilars Act

7 filings
H.R. 1
One Big Beautiful Bill Act

6 filings
S. 1105
No UPCODE Act

6 filings
H.R. 1197
PREEMIE Reauthorization Act of 2025

5 filings
H.R. 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

5 filings
H.R. 2509
COMPLETE Care Act

5 filings
H.R. 3841
Healthcare Cybersecurity Act of 2025

5 filings
H.R. 4570
Interagency Patent Coordination and Improvement Act of 2025

5 filings
H.R. 4710
No Surprises Act Enforcement Act

5 filings
S. 1097
Interagency Patent Coordination and Improvement Act of 2025

5 filings
S. 1302
Increasing Transparency in Generic Drug Applications Act

5 filings
S. 1851
Healthcare Cybersecurity Act of 2025

5 filings
S. 1954
Biosimilar Red Tape Elimination Act

5 filings
S. 2355
Patients Deserve Price Tags Act

5 filings
S. 2420
No Surprises Act Enforcement Act

5 filings
S. 2658
Medication Affordability and Patent Integrity Act

5 filings
S. 931
COMPLETE Care Act

5 filings
H.R. 3120
Healthy Competition for Better Care Act

4 filings
H.R. 3237
To amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provide…

4 filings
H.R. 3417
FAIR Act

4 filings
H.R. 3839
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

4 filings
H.R. 5378
Lower Costs, More Transparency Act

4 filings
H.R. 6033
SPEAK Act of 2024

4 filings
S. 1067
Ensuring Timely Access to Generics Act of 2023

4 filings
S. 1451
Healthy Competition for Better Care Act

4 filings

Reported by year 2 years

2026 $88,000 3 filings
2025 $118,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 7
SENATE 7

Recent filings 7 total

Q3 report

BCBSM, Inc.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 expenses · posted Oct 21, 2026

View → Q2 report

BCBSM, Inc.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $28,000 expenses · posted Jul 17, 2026

View → Q1 report

BCBSM, Inc.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $30,000 expenses · posted Apr 20, 2026

View → Q4 report

BCBSM, Inc.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $28,000 expenses · posted Jan 19, 2026

View → Q3 report

BCBSM, Inc.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $32,000 expenses · posted Oct 17, 2025

View → Q2 report

BCBSM, Inc.

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $30,000 expenses · posted Jul 18, 2025

View → Q1 report

BCBSM, Inc.

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $28,000 expenses · posted Apr 18, 2025

View →

Keep going

Filings through October 21, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.